Krystal Biotech, Inc. (KRYS)

371.47 +2.24 (+0.61%) USD  |  NASDAQ  |  Sep 03, 16:00
371.41 -0.06 (-0.02%) After-Hours: 20:00
More

Krystal Biotech Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Cytokinetics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade